www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

chinadaily.com.cn
left corner left corner
China Daily Website

Medical reforms spell out profit for pharma giants

Updated: 2013-04-13 14:37
By Liu Jie ( China Daily)

China now has 148 million people with pre-diabetes on top of an existing 92.4 million diabetes patients.

The number of patients is forecast to reach 130 million by 2030, creating medical costs related to type-2 diabetes of $47.2 billion, according to International Diabetes Federation.

In the China National Plan for Chronic Diseases Prevention and Treatment (2012-2015), diabetes has been given specific importance.

"Our advantage is in early-stage diabetes treatment. Our Glucophage (an oral diabetes medicine that helps control blood sugar levels) is recommended as initial treatment within national guidelines," said Jean-Christophe Pointeau, president of Bristol-Myers China.

The medicine is on China's essential drug list and Pointeau said he expects another Bristol-Myers product - Onglyza, a prescription type 2 diabetes medicine - also to be included.

Another major international name, Boston Scientific Co, has just announced clinical results of a trial evaluating the safety and effectiveness of a cardiovascular stent system in China.

Clinical trials are the prerequisite of new product introduction.

The US company is also working to introduce more specialist treatment to the Chinese market, including those involved in cardiology and endoscopy, especially in the treatment of chronic conditions, said Michael F. Mahoney, Boston Scientific's CEO.

Since entering China in 1997, the company's average annual growth by sales has kept at 30 percent and it expects to exceed that figure in coming years.

The company is also building a research and development, training and head office complex in Shanghai, which is expected to be completed in September.

China expects to increase its medical spending by 27 percent this year, and to more than double the number of drugs in its national reimbursement medicine list from 205 to 520.

China's medical insurance will cover an additional 20 serious illnesses, including lung and gastric cancers, chronic myelocytic leukemia, hemophilia, type-1 diabetes and cerebral infarction.

These are also other serious diseases seeing increased occurrence in China, which lack high-quality diagnosis and treatment equipment being produced by domestic companies, according to a recent report from Bank of China International (China) Ltd.

Sanofi's Lam added that so far the company cannot assess how successful its investment in the Chinese market has been, "but we believe in the long run, it will be absolutely positive to us".

Sanofi's diabetes business increased 25 percent year-on-year in 2012, compared with the average growth of the sector at 15 percent.

 
8.03K
 
...
主站蜘蛛池模板: 国产三级在线看 | 日韩欧国产精品一区综合无码 | 欧美另类在线视频 | 成人精品在线观看 | 成人精品视频在线 | 亚洲国产老鸭窝一区二区三区 | 欧美日韩色 | 在线播放波多野结衣 | 色三级大全高清视频在线观看 | 久久久精品影院 | 国产一国产一级毛片视频在线 | 114一级毛片免费 | 免费观看毛片视频 | 亚洲精品久久一区毛片 | 国产97视频 | 欧美精品国产制服第一页 | 久久久久久久国产精品 | 91精品国产色综合久久 | 精品老司机在线视频香蕉 | 国产精品亚洲精品爽爽 | 色视频在线观看视频 | 91福利国产在线观一区二区 | 日韩a一级欧美一级在线播放 | 亚洲毛片在线观看 | 日韩精品一区二三区中文 | 538在线视频二三区视视频 | 亚洲第一成年网 | 久久综合丁香 | 久久精品国产精品亚洲综合 | 操碰91 | 国产三及 | 真实国产普通话对白乱子子伦视频 | 欧美激情特级黄aa毛片 | 一品道一本香蕉视频 | 亚色成人 | 亚洲精品国产啊女成拍色拍 | 91精品久久久久含羞草 | 欧美成人午夜毛片免费影院 | 国产成人在线免费视频 | 九九亚洲 | 她也啪在线视频精品网站 |